Skip to content

APOTHEEK VAN OVERBERGE: what changed

BE 0422.879.913NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€75,781
2024 · €176,642-€100,861
Equity
€634,419
2024 · €558,638+€75,781
Cash
€196,183
2024 · €312,278-€116,095
Balance sheet total
€1.8m
2024 · €1.1m+€674,620

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€774,461

    up €774,461 (+166%), from €467,218 to €1.2m

    of which Land and buildings: +€654,212

  • Cash -€116,095

    down €116,095 (-37.2%), from €312,278 to €196,183

    mainly Investment in fixed assets (net) (-€825,241) and Tax, wage and social debts (-€12,179)

Equity and liabilities
  • Debts after one year +€512,500

    up €512,500 (+186%), from €275,000 to €787,500

  • Reserves +€75,781

    up €75,781 (+15.3%), from €496,638 to €572,419

    of which Distributable reserves: +€79,078

  • Current portion of long-term debt +€50,000

    up €50,000 (+200%), from €25,000 to €75,000

  • Other debts +€35,865

    up €35,865 (+28.9%), from €123,938 to €159,803

Income statement
  • Gross operating margin -€78,581

    down €78,581 (-24.1%), from €326,150 to €247,569

  • Depreciation +€35,214

    up €35,214 (+226%), from €15,566 to €50,780

  • Taxes -€21,303

    down €21,303 (-100%), from €21,303 to €0

  • Financial charges +€17,271

    up €17,271 (+311%), from €5,554 to €22,826

  • Staff costs -€9,178

    down €9,178 (-8.6%), from €106,376 to €97,198

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €176,642
Gross operating margin -€78,581
Staff costs +€9,178
Depreciation -€35,214
Other operating charges -€122
Financial income -€154
Financial charges -€17,271
Taxes +€21,303
Result 2025 €75,781
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€146,647
Investment -€825,241
Financing +€562,500
Cash 2024 €312,278
Net result for the year +€75,781
Depreciation +€50,780
Stocks and contracts -€5,593
Receivables within one year -€11,147
Smaller working-capital items -€612
Trade debts +€13,752
Tax, wage and social debts -€12,179
Other debts +€35,865
Investment in fixed assets (net) -€825,241
Debts after one year +€512,500
Current portion of long-term debt +€50,000
Cash 2025 €196,183
brings cash intakes cash out
Every line side by side 54 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,137,188 €1,811,807 +€674,620 +59.3%
Fixed assets 21/28 €472,218 €1,246,680 +€774,461 +164%
Tangible fixed assets 22/27 €467,218 €1,241,680 +€774,461 +166%
Land and buildings 22 €452,466 €1,106,677 +€654,212 +145%
Plant, machinery and equipment 23 €8,195 €130,023 +€121,829 +1,487%
Furniture and vehicles 24 €6,558 €4,979 -€1,579 -24.1%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €664,969 €565,128 -€99,842 -15.0%
Stocks and contracts in progress 3 €187,722 €193,316 +€5,593 +3.0%
Stocks 30/36 €187,722 €193,316 +€5,593 +3.0%
Amounts receivable within one year 40/41 €144,638 €155,784 +€11,147 +7.7%
Trade receivables 40 €139,537 €135,599 -€3,938 -2.8%
Other amounts receivable 41 €5,101 €20,185 +€15,084 +296%
Cash at bank and in hand 54/58 €312,278 €196,183 -€116,095 -37.2%
Deferred charges and accrued income 490/1 €20,332 €19,844 -€487 -2.4%
Total equity and liabilities 10/49 €1,137,188 €1,811,807 +€674,620 +59.3%
Equity 10/15 €558,638 €634,419 +€75,781 +13.6%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €496,638 €572,419 +€75,781 +15.3%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Tax-exempt reserves 132 €140,257 €136,959 -€3,297 -2.4%
Distributable reserves 133 €350,181 €429,260 +€79,078 +22.6%
Profit (loss) carried forward 14 €0 €0 =
Provisions and deferred taxes 16 €33,261 €32,162 -€1,099 -3.3%
Deferred taxes 168 €33,261 €32,162 -€1,099 -3.3%
Amounts payable 17/49 €545,289 €1,145,227 +€599,938 +110%
Amounts payable after more than one year 17 €275,000 €787,500 +€512,500 +186%
Financial debts 170/4 €275,000 €787,500 +€512,500 +186%
Amounts payable within one year 42/48 €270,290 €357,727 +€87,438 +32.3%
Current portion of amounts payable after more than one year 42 €25,000 €75,000 +€50,000 +200%
Trade debts 44 €94,223 €107,975 +€13,752 +14.6%
Suppliers 440/4 €94,223 €107,975 +€13,752 +14.6%
Taxes, remuneration and social security 45 €27,129 €14,949 -€12,179 -44.9%
Taxes 450/3 €7,012 €834 -€6,178 -88.1%
Remuneration and social security 454/9 €20,117 €14,115 -€6,002 -29.8%
Other amounts payable 47/48 €123,938 €159,803 +€35,865 +28.9%
Remuneration, social security and pensions 62 €106,376 €97,198 -€9,178 -8.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,566 €50,780 +€35,214 +226%
Other operating charges 640/8 €3,927 €4,049 +€122 +3.1%
Gross operating margin 9900 €326,150 €247,569 -€78,581 -24.1%
Operating profit (loss) 9901 €200,281 €95,543 -€104,738 -52.3%
Financial income 75/76B €2,119 €1,965 -€154 -7.2%
Recurring financial income 75 €2,119 €1,965 -€154 -7.2%
Financial charges 65/66B €5,554 €22,826 +€17,271 +311%
Recurring financial charges 65 €5,554 €22,826 +€17,271 +311%
Profit (loss) for the period before taxes 9903 €196,845 €74,682 -€122,163 -62.1%
Transfer from deferred taxes 780 €1,099 €1,099 = 0.0%
Income taxes 67/77 €21,303 €0 -€21,303 -100%
Profit (loss) for the period 9904 €176,642 €75,781 -€100,861 -57.1%
Transfer from tax-exempt reserves 789 €3,297 €3,297 = 0.0%
Profit (loss) for the period to be appropriated 9905 €179,939 €79,078 -€100,861 -56.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€799,613 to €992,574

Midpoint €880,013 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €634,419
Capitalised earnings €964,807 to €1.4m
Indication €799,613 to €992,574

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€634,419
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€634,419

Capitalised earnings

net result for the year (9904)
2025
€75,781
2024
€176,642
2023
€152,796
2022
€144,314
excluding non-recurring income and charges
€135,431
2021
€62,413
Average result
€135,073
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€964,807 / €1.1m / €1.4m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.